Leaders in health technology, data analytics and liver health join Chronwell, Inc.’s advisory board.
FORT LAUDERDALE, Florida., May 12, 2022 /PRNewswire/ — Chronwell, Inc., a digital health and therapeutics company that partners with medical practices to provide exceptional care beyond the walls of a clinic, recently announced the appointment of Donna CryerJD, Paul Hadad and Gary Leibowitz on the company’s board of directors.
Donna Cryer, Paul Hadad and Gary Leibowitz were recently appointed to the advisory board of Chronwell, Inc.
Ms. Cryer is the Founder, President and CEO of the Global Liver Institute, a patient-focused non-profit organization dedicated to improving the lives of individuals and families affected by liver disease around the world. Moved by her own experience as a liver transplant recipient, Cryer has become a powerful force in liver health, health policy and patient advocacy. She currently serves on the boards of the Council of Medical Specialty Societies, Sibley Memorial Hospital, part of Johns Hopkins Medicine, and the Clinical Trials Transformation Initiative.
Mr. Haddad is President and CEO of Fourthwall, a leading media and advertising analytics technology company and founder of Polmondi Ventures. Previously, he was Chairman of a4, Altice the United States advanced advertising and data solutions company, and senior vice president and general manager of Advanced Data Analytics for Cablevision.
Mr. Leibowitz is the founder and CEO of go-ESI, a software delivery company, and a recognized cybersecurity expert with advisory and director positions at SecurityGate.io, eatNgage, ThreatGen, AuthMind and HOU. SEC.CON, one Houston-conference on information security in the region. Leibowitz has extensive and diverse international experience in high technology marketing, sales, business development and general management.
dr. Joe Rubinsztain, CEO of ChronWell, said he was proud to welcome Cryer, Haddad and Leibowitz to the team. “Patient advocacy, science and data security are critical areas of digital therapy, and this team of world-class advisors is exactly what we need to support our rapid expansion,” he said. .
Chronwell recently announced its groundbreaking strategic partnership with ModifyHealth, a national provider of fully prepared, gut-friendly meals, and Echosens North America, a high-tech medical device company offering the FibroScan family of products. This collaboration created LiverHealthy, a newly integrated digital therapy program that provides better outcomes and best-in-class service for patients with non-alcoholic liver disease.
Chronwell is a digital health and therapy company targeting non-alcoholic liver disease and other related metabolic conditions in partnership with healthcare providers. ChronWell combines advanced digital therapies with highly trained care teams to improve patients’ lives beyond the walls of the doctor’s office and minimize the impact of chronic disease on patients, providers, employers and insurers. For more information, follow us on LinkedIn or visit chronwell.com.
Contact: Mary Guiden
Email: [email protected]
See original content to download multimedia: https://www.prnewswire.com/news-releases/healthcare-technology-data-analytics-liver-health-leaders-join-chronwell-incs-advisory-board-301546373.html